Skip to content

Effect of elemental diet on prognosis in patients with unresectable pancreatic cancer receiving chemotherapy (Observational study)

Effect of elemental diet on prognosis in patients with unresectable pancreatic cancer receiving chemotherapy (Observational study) - Effect of elemental diet in patients with unresectable pancreatic cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021093
Enrollment
20
Registered
2016-02-19
Start date
2016-02-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

None listed

Sponsors

Ehime University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients receiving chemotherapy for unresectable pancreatic cancer, and who gave a consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Age under 20 years 2. Allergy to Elental 3. Incontrolable diabetes 4. Pregnant women 5. Breastfeeding women 6. Patients with amino acid disorder 7. Patients whom physician considered unqualifiable

Design outcomes

Primary

MeasureTime frame
1. Adherence to chemotherapy 2. Adherence to elemental diet 3. Gastrointestinal symptoms 4. Change in nutrition status: body weight, WBC, Total protein, albumin, glucose, HbA1c, cholesterol, triglyceride, cholinesterase, CRP 5. Change in sarcopenia

Countries

Japan

Contacts

Public ContactTeru Kumagi

Ehime University Hospital Gastroenterology

terukuma@m.ehime-u.ac.jp089-960-5308

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026